// App-Quantinova.ai

: Safety and tolerability of immunosuppression in non-IPF ILD: clinical experience from a tertiary ILD centre

Researchers

Presenter

  • Conal Hayton

Principal Investigators

  • Fayez Elsawy

  • Theresa Garfoot

  • Colm Leonard

  • Pilar Rivera-Ortega

  • John Blaikley

  • Nazia Chaudhuri

Medical Centers

  • N/A

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A